Drugs / Lactobacillus acidophilus KS400
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| — | NCT07344064 | Feb → Jul 2026 overdue | bacterial vaginosis | Queen Savang Vadhana Memorial Hospital, Thailand | Not yet recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Lactobacillus acidophilus KS400 | “Gynoflor® vaginal tablets (containing Lactobacillus acidophilus KS400 and 0.03 mg estriol)” NCT07344064 ↗ |
| Route | Other | “1 tablet inserted vaginally at bedtime for 6 consecutive days” NCT07344064 ↗ |